West Pharmaceutical Services (WST)
(Real Time Quote from BATS)
$313.48 USD
-1.72 (-0.55%)
Updated Jun 7, 2024 10:18 AM ET
3-Hold of 5 3
D Value B Growth B Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
WST 313.48 -1.72(-0.55%)
Will WST be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for WST based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for WST
Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF (RSPH)?
West Pharmaceutical (WST) Q1 Earnings Beat, HVP Sales Weak
WST: What are Zacks experts saying now?
Zacks Private Portfolio Services
West Pharmaceutical Services (WST) Tops Q1 Earnings and Revenue Estimates
Conmed (CNMD) Surpasses Q1 Earnings and Revenue Estimates
Will West Pharmaceutical (WST) Beat Estimates Again in Its Next Earnings Report?
Other News for WST
West Pharmaceutical Services Inc. stock underperforms Wednesday when compared to competitors
Sell ideas in Staples and Health Care - Oppenheimer
West Introduces Daikyo Crystal Zenith® (CZ) Ready-to-Use Nested Vials in Tub at the International Society for Cell and Gene Therapy
10 Dividend Growth Stocks: May 2024
West to Participate in Upcoming Investor Conference